Tang Capital Management LLC Top Holdings and 13F Report (2024) About Tang Capital Management LLCInvestment ActivityTang Capital Management LLC has $1.40 billion in total holdings as of September 30, 2024.Tang Capital Management LLC owns shares of 154 different stocks, but just 50 companies or ETFs make up 80% of its holdings.Approximately 26.11% of the portfolio was purchased this quarter.About 3.98% of the portfolio was sold this quarter.This quarter, Tang Capital Management LLC has purchased 128 new stocks and bought additional shares in 43 stocks.Tang Capital Management LLC sold shares of 14 stocks and completely divested from 9 stocks this quarter.Largest Holdings Evolus $78,527,864Tarsus Pharmaceuticals $74,160,273Aurinia Pharmaceuticals $52,992,235Viridian Therapeutics $51,026,544Mirum Pharmaceuticals $50,197,173 Largest New Holdings this Quarter BioNTech $32,067,900 HoldingRelay Therapeutics $25,261,851 HoldingiTeos Therapeutics $24,583,638 HoldingNeurocrine Biosciences $17,283,000 HoldingNovavax $12,630,000 Holding Largest Purchases this Quarter Aurinia Pharmaceuticals 4,450,000 shares (about $32.62M)BioNTech 270,000 shares (about $32.07M)Relay Therapeutics 3,568,058 shares (about $25.26M)iTeos Therapeutics 2,407,800 shares (about $24.58M)Immunocore 700,000 shares (about $21.79M) Largest Sales this Quarter Dynavax Technologies 600,000 shares (about $6.68M)Beam Therapeutics 100,000 shares (about $2.45M)CRISPR Therapeutics 50,000 shares (about $2.35M)Seres Therapeutics 2,207,112 shares (about $2.09M)Enanta Pharmaceuticals 173,345 shares (about $1.80M) Sector Allocation Over TimeMap of 500 Largest Holdings ofTang Capital Management LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorEOLSEvolus$78,527,8640.0%4,847,3995.6%MedicalTARSTarsus Pharmaceuticals$74,160,2730.0%2,254,7975.3%MedicalAUPHAurinia Pharmaceuticals$52,992,235$32,618,500 ▲160.1%7,229,5003.8%MedicalVRDNViridian Therapeutics$51,026,544$19,337,500 ▲61.0%2,242,9253.6%MedicalMIRMMirum Pharmaceuticals$50,197,1730.0%1,287,1073.6%MedicalKALVKalVista Pharmaceuticals$50,043,514$1,189,474 ▲2.4%4,321,5473.6%MedicalANABAnaptysBio$44,584,4470.0%1,330,8793.2%MedicalIMCRImmunocore$34,417,328$21,791,000 ▲172.6%1,105,6002.5%MedicalPCVXVaxcyte$34,281,0000.0%300,0002.4%MedicalBNTXBioNTech$32,067,900$32,067,900 ▲New Holding270,0002.3%MedicalANIPANI Pharmaceuticals$26,847,0000.0%450,0001.9%MedicalPTCTPTC Therapeutics$25,970,0000.0%700,0001.9%MedicalRLAYRelay Therapeutics$25,261,851$25,261,851 ▲New Holding3,568,0581.8%MedicalITOSiTeos Therapeutics$24,583,638$24,583,638 ▲New Holding2,407,8001.8%MedicalAPLTApplied Therapeutics$23,205,000$3,400,000 ▲17.2%2,730,0001.7%MedicalACADACADIA Pharmaceuticals$23,070,0000.0%1,500,0001.6%MedicalITCIIntra-Cellular Therapies$21,951,0000.0%300,0001.6%MedicalDVAXDynavax Technologies$21,166,000$6,684,000 ▼-24.0%1,900,0001.5%MedicalGLPGGalapagos$20,153,000$18,552,017 ▲1,158.8%700,0001.4%MedicalGSKGSK$18,396,000$2,044,000 ▲12.5%450,0001.3%MedicalLENZ THERAPEUTICS INC$18,207,156$458,752 ▲2.6%766,9401.3%COMNVDANVIDIA$17,940,533$3,972,658 ▲28.4%147,7321.3%Computer and TechnologyNBIXNeurocrine Biosciences$17,283,000$17,283,000 ▲New Holding150,0001.2%MedicalALTAltimmune$16,885,0000.0%2,750,0001.2%MedicalAVADEL PHARMACEUTICALS PLC$16,131,4500.0%1,230,0001.2%COM SHSKINIKSA PHARMACEUTICALS INTL$15,708,939$82,467 ▲0.5%628,6091.1%ORD SHS CL AJAZZJazz Pharmaceuticals$15,597,4000.0%140,0001.1%MedicalAVIRAtea Pharmaceuticals$15,433,651$436,569 ▲2.9%4,607,0601.1%MedicalCGEMCullinan Therapeutics$15,419,8500.0%921,1381.1%MedicalMETAMeta Platforms$14,800,697$8,277,056 ▲126.9%25,8551.1%Computer and TechnologyRCKTRocket Pharmaceuticals$13,852,5000.0%750,0001.0%MedicalZYMEZymeworks$13,805,0000.0%1,100,0001.0%MedicalREPLReplimune Group$13,152,000$4,324,378 ▲49.0%1,200,0000.9%MedicalRVNCRevance Therapeutics$12,975,000$10,899,000 ▲525.0%2,500,0000.9%MedicalCARGO THERAPEUTICS INC$12,928,819$2,362,559 ▲22.4%700,7490.9%COMTDOCTeladoc Health$12,852,000$3,672,000 ▲40.0%1,400,0000.9%MedicalNVAXNovavax$12,630,000$12,630,000 ▲New Holding1,000,0000.9%MedicalCRSPCRISPR Therapeutics$12,520,170$2,349,000 ▼-15.8%266,5000.9%MedicalCRBPCorbus Pharmaceuticals$12,378,000$12,378,000 ▲New Holding600,0000.9%MedicalACETAdicet Bio$11,832,4220.0%8,216,9600.8%MedicalAZNAstraZeneca$11,686,5000.0%150,0000.8%MedicalHRMYHarmony Biosciences$11,248,0000.0%281,2000.8%MedicalVNDAVanda Pharmaceuticals$11,037,010$938,000 ▲9.3%2,353,3070.8%MedicalIMNMImmunome$10,526,4000.0%720,0000.8%MedicalCTMXCytomX Therapeutics$9,217,877$23,392 ▲0.3%7,811,7600.7%MedicalNUVBNuvation Bio$8,931,000$339,231 ▲3.9%3,900,0000.6%MedicalELANElanco Animal Health$8,814,000$8,814,000 ▲New Holding600,0000.6%MedicalHLVXHilleVax$8,659,200$8,659,200 ▲New Holding4,920,0000.6%MedicalOUTLOOK THERAPEUTICS INC$8,328,050$319,610 ▼-3.7%1,559,5600.6%COMBGNEBeiGene$8,306,8700.0%37,0000.6%MedicalMRNSMarinus Pharmaceuticals$8,272,000$176,000 ▼-2.1%4,700,0000.6%MedicalLQDALiquidia$8,000,000$4,500,000 ▲128.6%800,0000.6%MedicalDSGNDesign Therapeutics$7,967,6460.0%1,480,9750.6%MedicalALXOALX Oncology$7,652,618$7,652,618 ▲New Holding4,204,7350.5%MedicalVKTXViking Therapeutics$7,597,2000.0%120,0000.5%MedicalINSMInsmed$7,300,0000.0%100,0000.5%MedicalDIANTHUS THERAPEUTICS INC$7,247,2670.0%264,6920.5%COMBHVNBiohaven$6,995,8000.0%140,0000.5%MedicalBIIBBiogen$6,784,4000.0%35,0000.5%MedicalVTYXVentyx Biosciences$6,758,0000.0%3,100,0000.5%MedicalBLCOBausch + Lomb$6,751,500$6,751,500 ▲New Holding350,0000.5%MedicalCNTACentessa Pharmaceuticals$6,396,000$6,396,000 ▲New Holding400,0000.5%MedicalGPCRStructure Therapeutics$6,342,1050.0%144,5000.5%MedicalBCRXBioCryst Pharmaceuticals$6,080,0000.0%800,0000.4%MedicalIONSIonis Pharmaceuticals$6,009,0000.0%150,0000.4%MedicalABCLAbCellera Biologics$5,980,000$4,779,583 ▲398.2%2,300,0000.4%MedicalBDTXBlack Diamond Therapeutics$5,960,409$1,013,511 ▼-14.5%1,370,2090.4%MedicalAPOGEE THERAPEUTICS INC$5,874,0000.0%100,0000.4%COMSINGULAR GENOMICS SYSTEMS IN$5,829,240$5,829,240 ▲New Holding372,0000.4%COM NEWPRECISION BIOSCIENCES INC$5,585,0550.0%623,3320.4%COM NEWLNTHLantheus$5,487,5000.0%50,0000.4%MedicalCYTKCytokinetics$5,280,0000.0%100,0000.4%MedicalNUVLNuvalent$5,115,000$5,115,000 ▲New Holding50,0000.4%MedicalRPHMReneo Pharmaceuticals$5,008,642$85,000 ▼-1.7%2,946,2600.4%MedicalMRUSMerus$4,996,0000.0%100,0000.4%MedicalAREAlexandria Real Estate Equities$4,750,0000.0%40,0000.3%FinanceIOVAIovance Biotherapeutics$4,695,0000.0%500,0000.3%MedicalALUMIS INC$4,556,024$4,556,024 ▲New Holding426,5940.3%COMSEERSeer$4,531,0000.0%2,300,0000.3%MedicalARVNArvinas$4,433,4000.0%180,0000.3%MedicalBEAMBeam Therapeutics$4,165,000$2,450,000 ▼-37.0%170,0000.3%MedicalSNYSanofi$4,034,100$4,034,100 ▲New Holding70,0000.3%MedicalCCCCC4 Therapeutics$3,990,000$2,850,000 ▲250.0%700,0000.3%MedicalHRTXHeron Therapeutics$3,681,5000.0%1,850,0000.3%MedicalCYBIN INC$3,556,000$3,556,000 ▲New Holding400,0000.3%COM NEWTYRATyra Biosciences$3,526,500$2,533,837 ▲255.3%150,0000.3%MedicalCMPXCompass Therapeutics$3,335,911$3,335,911 ▲New Holding1,812,9950.2%MedicalNKTXNkarta$2,938,000$452,000 ▲18.2%650,0000.2%MedicalELEVElevation Oncology$2,855,524$1,019,830 ▲55.6%4,760,0000.2%MedicalKZRKezar Life Sciences$2,814,680$2,814,680 ▲New Holding3,640,3000.2%MedicalBOLTBolt Biotherapeutics$2,470,6770.0%3,812,7730.2%MedicalFATEFate Therapeutics$2,450,0000.0%700,0000.2%MedicalCHRSCoherus BioSciences$2,444,000$1,352,000 ▲123.8%2,350,0000.2%MedicalGMABGenmab A/S$2,438,0000.0%100,0000.2%MedicalTECTONIC THERAPEUTIC INC$2,398,7290.0%79,1660.2%COMSWTXSpringWorks Therapeutics$2,379,451$2,379,451 ▲New Holding74,2650.2%MedicalTGTXTG Therapeutics$2,339,0000.0%100,0000.2%MedicalTBPHTheravance Biopharma$2,118,942$2,118,942 ▲New Holding262,8960.2%MedicalKURAKura Oncology$1,954,0000.0%100,0000.1%MedicalIPSCCentury Therapeutics$1,539,0000.0%900,0000.1%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
